EARNINGS 
Syntex Corp.: The Palo Alto-based pharmaceutical firm reported a profit of 
$303.2 million for 1989, up 2% over the previous year. Sales totaled $1.3 
billion, up 6%. In the fourth quarter, net income fell 25% to $50.4 million 
because of lower U.S. sales of Naprosyn as a result of additional competition 
from two new anti-inflammatory prescription drugs. Sales during the period 
slipped 3% to $321.1 million. 
